| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/28/1997 | CN1150760A Methods for inducing T cell tolerance to tissue or organ graft |
| 05/28/1997 | CN1150754A Human osteoclast-derived cathepsin |
| 05/27/1997 | US5633425 Transgenic non-human animals capable of producing heterologous antibodies |
| 05/27/1997 | US5633348 Amphotropic virus receptor |
| 05/27/1997 | US5633162 Method for culturing Chinese hamster ovary cells |
| 05/27/1997 | US5633149 Polynucleotide encoding novel chemokine expressed in inflamed adenoid |
| 05/27/1997 | US5633147 Transforming growth factor αH1 |
| 05/27/1997 | US5633142 WT1 monoclonal antibodies and methods of use therefor |
| 05/27/1997 | US5633141 Assaying platelet factor 4 neutrophil agonists |
| 05/27/1997 | US5633136 ALL-1 polynucleotides for leukemia detection and treatment |
| 05/27/1997 | US5632993 Immunogens and the use thereof for obtaining antibodies against HbA1c |
| 05/27/1997 | US5632991 Antibodies specific for E-selectin and the uses thereof |
| 05/27/1997 | US5632990 Linked to carboxypeptidase or nitroreductase; anticarcinogenic agents |
| 05/27/1997 | US5632989 Screening with a monoclonal antibodies |
| 05/27/1997 | US5632968 Detection of cardiovascular lesions |
| 05/27/1997 | CA1339047C Production of erythropoietin |
| 05/22/1997 | WO1997018475A1 Compounds and methods for the detection and prevention of t. cruzi infection |
| 05/22/1997 | WO1997018333A1 Disruption of expression of multiple alleles of mammalian genes |
| 05/22/1997 | WO1997018315A1 Hybrid factor viii with modified activity |
| 05/22/1997 | WO1997018301A1 Synthetic hpv11 virus-like particles |
| 05/22/1997 | WO1997018300A2 Murine model for human carcinoma |
| 05/22/1997 | WO1997018236A1 MIMOTOPES AND ANTI-MIMOTOPES OF HUMAN PLATELET GLYCOPROTEIN Ib/IX |
| 05/22/1997 | WO1997018230A1 Cloning and expression of beta app-c100 receptor (c100-r) |
| 05/22/1997 | WO1997018229A1 Parasitic helminth macrophage migration inhibitory factor proteins, nucleic acid molecules, and uses thereof |
| 05/22/1997 | WO1997017993A1 Tumor associated internalizing antigens and methods for targeting therapeutic agents |
| 05/22/1997 | WO1997017984A1 Oligodendrocyte-specific protein and method for treating disease |
| 05/22/1997 | WO1997017980A1 Treatment of cardiomyopathy by removal of autoantibodies |
| 05/22/1997 | WO1997007135A3 Binding of osteogenic protein-i (op-1) and analogs thereof to the cell surface receptor alk-1 and analogs thereof |
| 05/22/1997 | WO1996041606A3 Improved pharmaceutical compositions for gene therapy |
| 05/22/1997 | CA2238007A1 Cloning and expression of .beta.app-c100 receptor (c100-r) |
| 05/22/1997 | CA2237818A1 Parasitic helminth macrophage migration inhibitory factor proteins, nucleic acid molecules, and uses thereof |
| 05/22/1997 | CA2235628A1 Hybrid factor viii with modified activity |
| 05/22/1997 | CA2234661A1 Mimotopes and anti-mimotopes of human platelet glycoprotein ib/ix |
| 05/22/1997 | CA2210650A1 Cell cycle checkpoint pik-related kinase materials and methods |
| 05/21/1997 | EP0774515A2 Fluorescence polarization detection of nucleic acids |
| 05/21/1997 | EP0774513A1 RECOMBINANT HERPESVIRUS WITH THE USE OF gB GENE PROMOTER |
| 05/21/1997 | EP0774511A1 Methods of producing members of specific binding pairs |
| 05/21/1997 | EP0774262A1 Pharmaceutical compositions comprising a neutralized virus and use thereof |
| 05/21/1997 | EP0774250A1 Use of a TNF alpha antagonist against skin redness of neurogenic origin |
| 05/21/1997 | EP0774118A2 Target specific screens and their use for discovering small organic molecular pharmacophores |
| 05/21/1997 | EP0774004A1 Dna sequences coding for the human proteins tx and ty related to the interleukin-1beta converting enzyme |
| 05/21/1997 | EP0774000A1 Antibodies that bind a conformationally altered cd4 molecule induced upon human immunodefficiency virus binding |
| 05/21/1997 | EP0773997A2 Htk ligand |
| 05/21/1997 | EP0773995A1 Dna encoding the vertebrate homolog of hedgehog, vhh-1, expressed by the notochord, and uses thereof |
| 05/21/1997 | EP0773994A1 Receptor-ligand assay |
| 05/21/1997 | EP0773962A1 Antibodies which activate an erythropoietin receptor |
| 05/21/1997 | EP0773959A1 Adrenergic receptor |
| 05/21/1997 | EP0773793A1 Treatment of autoimmune diseases |
| 05/21/1997 | EP0658195B1 Virus obtainable from human neuroblastoma cells |
| 05/21/1997 | EP0557448A4 Preparation of nucleic acid samples |
| 05/21/1997 | EP0472725B1 Treatment of polycystic ovarian disease |
| 05/21/1997 | CN1150390A Glial mitogenic factors, their preparation and use |
| 05/21/1997 | CN1034976C Method for determining producing mucin antigen cell |
| 05/20/1997 | US5631351 Antibodies to MDC proteins |
| 05/20/1997 | US5631350 Anti-human influenza virus antibody |
| 05/20/1997 | US5631349 Chimeric monoclonal antibodies recognizing human interleukin-2-receptor |
| 05/20/1997 | US5631283 Use of sialic acid or antibodies to sialidase as anti-infectious agents and anti-inflammatory agents |
| 05/20/1997 | US5631172 Lead assay |
| 05/20/1997 | US5631158 Methods and compositions for high protein production from non-native DNA |
| 05/20/1997 | US5631131 cDNA probes and antibodies for human methenyltetrahydrofolate synthetase |
| 05/20/1997 | US5631009 Erythrocytes and reaction with antisera and antibodies |
| 05/15/1997 | WO1997017470A1 Detection of mammary tumor virus-like sequences in human breast cancer |
| 05/15/1997 | WO1997017446A2 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
| 05/15/1997 | WO1997017445A1 Method for treating neurodegenerative diseases using a 1c2 antibody or a fragment or derivative thereof, and corresponding pharmaceutical compositions |
| 05/15/1997 | WO1997017440A1 Neuropeptide y-y5 receptor |
| 05/15/1997 | WO1997017374A1 Recombinant ligands for the human cell membrane antigen cd30 |
| 05/15/1997 | WO1997017373A1 Tryptase polyclonal antibody and purification method for use in human tryptase immunoassay |
| 05/15/1997 | WO1997017372A1 Production of antibodies, and medical uses involving antibodies |
| 05/15/1997 | WO1997017371A1 ISOLATION OF apo(a), COMPOSITIONS, AND METHODS OF USE |
| 05/15/1997 | WO1997017368A1 Cd100 antigen and uses therefor |
| 05/15/1997 | WO1997017361A1 IgG SEPARATION MEDIUM AND NOVEL PROTEIN A VARIANT |
| 05/15/1997 | WO1997017360A2 Methods for modulating t cell responses by manipulating a common cytokine receptor gamma chain |
| 05/15/1997 | WO1997017089A1 Prophylactic immune milk preparation against otitis |
| 05/15/1997 | WO1997017084A1 Drug, in particular for modulating the immunological response for the control of viruses, tumours, bacteria and parasites |
| 05/15/1997 | WO1997017037A1 Intraoral administration device and system |
| 05/15/1997 | WO1997013781A3 Synthetic peptides that inhibit il-6 activity |
| 05/15/1997 | WO1997011093A3 Parainfluenza virus glycoproteins and vaccines |
| 05/15/1997 | WO1996032480A3 METHODS AND COMPOSITIONS FOR DETERMINING HER-2/neu EXPRESSION |
| 05/15/1997 | DE19534763C1 FMR1-verwandtes Protein FMR1-related protein |
| 05/15/1997 | CA2237183A1 Huntingtin-associated protein |
| 05/15/1997 | CA2235631A1 Neuropeptide y-y5 receptor |
| 05/15/1997 | CA2229444A1 Tryptase polyclonal antibody and purification method for use in human tryptase immunoassay |
| 05/14/1997 | EP0773291A2 Brain-specific adapter molecule, gene thereof, and antibody thereto |
| 05/14/1997 | EP0773288A2 Chimeric animal and method for producing the same |
| 05/14/1997 | EP0773228A1 Method of producing human monoclonal antibodies and their use |
| 05/14/1997 | EP0772780A1 Method for determining the lysine content of seeds |
| 05/14/1997 | EP0772634A1 Monoclonal antibodies specific for an epitope of a particular subclass or form of phosphorylated tau, hybridomas secreting them, antigen recognition of these antibodies and their applications |
| 05/14/1997 | EP0772449A1 Pharmaceutical compositions comprising a chimaeric tnf binding protein |
| 05/14/1997 | EP0640145B1 Measurement of an enzyme marker as an aid to diagnosis |
| 05/14/1997 | CN1149887A Compounds and methods for stimulation and enhancement of protective immune responses and IL-12 production |
| 05/13/1997 | US5629415 Genetic engineering |
| 05/13/1997 | US5629408 Immunochemical isolation of in vivo advanced glycosylation endproducts |
| 05/13/1997 | US5629204 Peptide related to human programmed cell death and DNA encoding it |
| 05/13/1997 | US5629197 Monoclonal anti-human breast cancer antibodies |
| 05/13/1997 | US5629193 Paraoxonase |
| 05/13/1997 | US5629174 Dna, rna |
| 05/13/1997 | US5629165 Calpastatins, detection of neurodegenerative conditions such as alzheimer*s disease by reaction with antibody |
| 05/13/1997 | US5629162 Method of identifying agents which modulate ICAM-3 binding to LFA-1 |
| 05/13/1997 | US5629161 Use of human papillomavirus gene derived peptides for diagnosis |
| 05/13/1997 | US5629160 Diagnostic assay for inhibitor of tissue-type and urokinase-type plasminogen activators, and gene coding for the inhibitor |